To evaluate topical antiseptic strategies in laboring women and newborns to reduce bacterial load in the maternal genital tract and on neonatal skin, emphasizing the urgent need for effective regimens to prevent neonatal sepsis in low-income countries.
Key Findings:
Infection is a major cause of neonatal mortality, with serious bacterial infections responsible for approximately 680,000 neonatal deaths per year in low-income countries.
Chlorhexidine (CHG) and octenidine with phenoxyethanol (OHP) are inexpensive antiseptics that may reduce bacterial load, though evidence for clinical benefit is mixed, with some studies showing no reduction in early-onset sepsis.
Interpretation:
Large pragmatic trials are needed to determine the effectiveness of maternal or neonatal antiseptic use in reducing neonatal sepsis and maternal infections in moderate- to high-incidence settings, highlighting the need for prioritizing effective strategies.
Limitations:
The study was conducted in a single location, which may limit generalizability and introduce potential confounding factors due to unblinding.
Participants were unblinded, which could introduce bias.
Conclusion:
The trial aims to identify effective antiseptic regimens for preventing neonatal sepsis in low-income countries, underscoring the significance of these findings for improving neonatal health.
by Emily Beales, Michelle N. Clements, Nicholas A. Feasey, David Lissauer, Maranatha Banda, Bertha Maseko, Julia A. Bielicki, Samantha Lissauer, Aisleen Bennett, Kondwani Kawaza, Luis A. Gadama, A. Sarah Walker, Mike Sharland, Louise F. Hill
